RE:Rights to our Ph. 2b data is worth more than the stockI am nowhere close to an expert on biotech value but I surely have learned that the current market cap really means nothing. Judging by other deals I cant see us having a value of anything short of 3B. Now one could say sure once we get BTD . However there are ways to structure a deal now that would allow for that milestone. My point continues to be that I dont think the powerful pharma companies will let this slip away . A deal could be made pending BTD. That is how I would do it so as to get the jump!!! Just thinking out loud here!